FDA product code OCL: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue

OCL is the FDA product code for surgical device, for cutting, coagulation, and/or ablation of tissue, including cardiac tissue. It is a Class II device, regulated under 21 CFR 878.4400 and reviewed by the Cardiovascular panel. FDA has cleared 54 510(k) submissions under OCL, 4 in the last five years, from 14 different applicants. The average 510(k) review took 105 days (median 80); 132 days on average over the last three years. FDA has posted 17 recalls for OCL devices, 1 initiated in the last five years.

Definition

Surgical device for cutting, coagulation, and/or ablation of tissue, including cardiac tissue

Classification

FieldValue
Device nameSurgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
Device classClass II
Regulation21 CFR 878.4400
Review panelCV — Cardiovascular
Medical specialtyGeneral, Plastic Surgery
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for OCL

YearClearancesAvg. review days
2017129
2018259
2019679
2020193
2021292
20222132
20241242
2025123

Compare with all 510(k) review times · Search every OCL clearance

Top OCL applicants

ApplicantClearancesLatest
AtriCure, Inc.202025-07-24
Medtronic, Inc.72022-12-22
Ncontact Surgical, Inc.62014-10-28
Medtronic42020-06-03
Cryocath Technologies, Inc.32006-08-24

9 more applicants have OCL clearances. See the full list in Caduvo.

Most recent OCL clearances

510(k)ApplicantDeviceDecision dateReview days
K252056AtriCure, Inc.Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)2025-07-2423
K234151AtriCure, Inc.Isolator Synergy EnCapture Ablation System (EMH)2024-08-27242
K221358AtriCure, Inc.Isolator® Linear Pen (MLP1); Isolator® Transpolar™ Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy™ EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1)2022-12-30233
K223508Medtronic, Inc.Cardioblate Gemini-s 49260 Surgical Ablation Device; Cardioblate Gemini-s 49351 Surgical Ablation Device2022-12-2230
K210477AtriCure, Inc.AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDE2021-07-26157

Recalls for OCL devices

17 product recalls in 10 recall events; 1 initiated in the last five years and 2 still open. Most recent: 2022-04-20.

YearRecalls
20195
20204
20211
20221

Frequently asked questions

What is FDA product code OCL?

OCL is the FDA product code for surgical device, for cutting, coagulation, and/or ablation of tissue, including cardiac tissue. It is a Class II device, regulated under 21 CFR 878.4400 and reviewed by the Cardiovascular panel.

What device class is OCL?

Class II, regulation 21 CFR 878.4400. Typical premarket route: 510(k).

How long does a 510(k) take for product code OCL?

Across 54 cleared submissions the average was 105 days from receipt to decision (median 80).

Which companies have the most OCL clearances?

AtriCure, Inc. (20); Medtronic, Inc. (7); Ncontact Surgical, Inc. (6); Medtronic (4); Cryocath Technologies, Inc. (3).

Have OCL devices been recalled?

Yes: 17 product recalls across 10 recall events; the most recent began 2022-04-20.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times